AMICUS THERAPEUTICS, INC. — Director's Dealing 2021

May 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2021-05-18

Reporting Person: RAAB MICHAEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-18	Common Stock	M	5634	$7.56	Acquired	26634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-18	Stock Options (right to buy)	$7.56	M	5634	Disposed	2021-05-24	Common Stock (5634)	Direct

Footnotes

F1: All of the options were fully vested and exercisable as of the transaction date.